Pharming B.V.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Pharming B.V.
Live alerts from global media, monitored by Business Radar
2025-06-30 (afm.nl)
Result from register substantial holdings and gross short positions
Result from register substantial holdings and gross short positions
Read more
2025-02-21 (iex.nl)
Asian Tech is good, AEX in Neutral and Heijmans supplies again
A quieter day after all that recent number violence. News from Pharming, figures from Brunel and Heijmans, and that Alibaba keeps going.
Read more
2025-01-21 (iex.nl)
A new Trump era: AEX opens flat even after 40 decrees
The biggest surprise was the decree that did not come. Pharming and Fastned have news, Davos chats about AI.
Read more
2024-12-19 (iex.nl)
RBC significantly increases Pharming price target
RBC increased the price target for Pharming Group from 1.60 to 2.15 euros on Thursday and maintained the Outperform recommendation. This was evident from an analyst report from RBC.
Read more
2024-12-19 (iex.nl)
RBC significantly increases Pharming price target
RBC increased the price target for Pharming Group from 1.60 to 2.15 euros on Thursday and maintained the Outperform recommendation. This was evident from an analyst report from RBC.
Read more
2024-12-19 (iex.nl)
RBC significantly increases Pharming price target
RBC increased the price target for Pharming Group from 1.60 to 2.15 euros on Thursday and maintained the Outperform recommendation. This was evident from an analyst report from RBC.
Read more
2024-12-19 (iex.nl)
RBC significantly increases Pharming price target
RBC increased the price target for Pharming Group from 1.60 to 2.15 euros on Thursday and maintained the Outperform recommendation. This was evident from an analyst report from RBC.
Read more
2024-12-19 (iex.nl)
RBC significantly increases Pharming price target
RBC increased the price target for Pharming Group from 1.60 to 2.15 euros on Thursday and maintained the Outperform recommendation. This was evident from an analyst report from RBC.
Read more
2024-12-11 (nd.nl)
Pharming is waiting for Damrak to rise after study results - Nederlands Dagblad. The quality newspaper of Christian Netherlands
Pharming was among the risers on the Amsterdam stock exchange on Wednesday. The biotechnologist announced that he had achieved positive results with research into the effectiveness of the drug leniolisib in the treatment of children aged four to eleven years with APDS, a rare disorder of the immune system. With this data, Pharming plans to begin filing worldwide approvals for leniolisib for the treatment of pediatric patients with APDS in 2025. The share was almost 7 percent higher.
Read more
2024-12-11 (iex.nl)
AEX is heading for a flat opening, Pharming and quantum chip Alphabet steal the show
AEX is heading for a fractionally lower opening. Waiting for US inflation. And also: super chip Willow, reshuffle Nasdaq 100 and Pharming.
Read more
2024-12-11 (iex.nl)
AEX is heading for a flat opening, Pharming and quantum chip Alphabet steal the show
AEX is heading for a fractionally lower opening. Waiting for US inflation. And also: super chip Willow, reshuffle Nasdaq 100 and Pharming.
Read more
2024-12-11 (iex.nl)
AEX is heading for a flat opening, Pharming and quantum chip Alphabet steal the show
AEX is heading for a fractionally lower opening. Waiting for US inflation. And also: super chip Willow, reshuffle Nasdaq 100 and Pharming.
Read more